$235.99▼ 54.07 (18.64%)
Real-time prices · US MarketsHigh-quality business with 32% return on equity and 18% profit margins.
Quality
8.5
Health
7.6
Growth
6.4
Valuation
5.7
Sentiment
5.8
Analyst Target
$248.90
▲ +5.5% from current
Price Chart
Latest News
- Illumina (ILMN) Lifts Outlook Following Q3 Results But Valuation Still Looks Stretched
- Illumina Crashes As Tariffs, AI Woes Eat Into 157% Run-Up
- Clinical Genomics Interpretation Platforms Global Market Report 2026 | Capitalize on AI and Cloud Growth Through 2030 with Thermo Fisher, Illumina, QIAGEN, and Tempus AI
Fundamentals
Trailing P/E
44.0×
price-to-earnings
Forward P/E
38.5×
next 12 months est.
Market Cap
$35.6B
market capitalization
Div Yield
0.00%
dividend yield
Profit Margin
18.3%
net profit margin
Gross Margin
67.9%
revenue minus COGS
ROE
32.3%
return on equity
Beta
1.42
vs S&P 500
52-Week Range
$106 — $309
annual min — max
EPS — Estimate vs Actual
Frequently Asked Questions
What do analysts say about Illumina, Inc. right now?
Illumina, Inc.'s Q·Score is 6.9/10 (Neutral), reflecting its current fundamentals, analyst data, and valuation metrics. High-quality business with 32% return on equity and 18% profit margins. This is an informational data summary only and does not constitute financial advice. Always do your own research before making any investment decision.
What is the analyst price target for ILMN?
The consensus price target for ILMN is $248.90, based on ratings from 20 Wall Street analysts. This is 5.5% above the current price of $235.99. Price targets are forward-looking estimates and not guarantees of future performance.
Is ILMN overvalued or undervalued?
Illumina, Inc. (ILMN) scores in line with sector averages on valuation metrics. Its forward P/E ratio stands at 38.5×. The consensus analyst price target of $248.90 is 5% above the current price.
What is Illumina, Inc.'s profit margin?
Illumina, Inc. has a net profit margin of 18.3%, which is solid for most industries. Its gross margin stands at 67.9%, indicating a high-margin business model.
Is Illumina, Inc.'s revenue growing?
Illumina, Inc. is reporting modest revenue growth of 9.4%. However, earnings declined 9.4%, which warrants monitoring.
How much debt does Illumina, Inc. have?
Illumina, Inc. has a debt-to-equity ratio of 0.89×, reflecting a moderate debt level, which is manageable for most profitable companies. Its current ratio is 1.80×, indicating comfortable short-term liquidity.
Compare ILMN with any stock